The Chan Zuckerberg Initiative has launched rBio, an AI model designed to reason about cellular biology using virtual simulations, thereby reducing reliance on costly lab experiments. This innovative approach employs "soft verification" and reinforcement learning to provide accurate predictions about biological processes, potentially accelerating biomedical research and drug discovery.